Advertisement


Related Videos

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

David A. Hyman, MD, JD, on Inclusive Shared Savings

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement



Nov
27
Today In Oncology
UICC Outlines Antimicrobial Resistance in Cancer Treatment
Personalized Breast Cancer Screening Model May Improve Outcomes and Reduce Overdiagnosis
Long-Term Quality-of-Life and Cognition Outcomes in Patients Receiving SRS vs WBRT for Resected Brain Metastasis
More Cancers Are Diagnosed at an Advanced Stage if Patients Already Have Type 2 Diabetes
Trametinib With or Without Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma
View More 
Advertisement
© 2022 HSP News Service, L.L.C.
Designed by Harborside